期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Ultrasound-guided percutaneous catheter drainage in early treatment of severe acute pancreatitis 被引量:8
1
作者 Xin-bo Ai Xiao-ping Qian +4 位作者 Wen-sheng Pan Jun Xu, Liang-qing Wu wan-jun zhang An Wang 《World Journal of Emergency Medicine》 SCIE CAS 2010年第1期45-48,共4页
Percutaneous catheter drainage (PCD) is a minimally invasive intervation for severe acute pancreatitis (SAP). This study was undertaken to compare the results of surgery and ultrasound-guided PCD in the treatment ... Percutaneous catheter drainage (PCD) is a minimally invasive intervation for severe acute pancreatitis (SAP). This study was undertaken to compare the results of surgery and ultrasound-guided PCD in the treatment of 32 patients with SAP, and to direct clinicians to the most optimal approach for SAP. In the 32 patients, 19 were proved to have deteriorated clinical signs or symptoms, extensive fluid exudation, and necrosis confirmed by computed tomography (CT) and they underwent operative debridement and drainage. For extensive fluid exudation or necrosis, complete liquefaction and safe catheter implantation, the other 13 patients were given PCD. The mortality rate of the surgery group was 26.3%, much higher than that of the PCD group (0%). There was a significant difference between the two groups (P=0.044). The mean time for recovery of the serum C-reactive protein (CRP) level was 43.8 days in the surgery group, which was significantly longer than that of the PCD group (23.8 days) (P=0.034). Early PCD guided by ultrasound could decrease the mortality of patients with severe acute pancreatitis, alleviate life-threatening inflammatory complications, and avoid unnecessary emergency operation. 展开更多
关键词 Percutaneous catheter drainage Operation Severe acute pancreatitis Clinicalefficacy
下载PDF
Epstein–Barr-virus-associated hepatitis with aplastic anemia: A case report
2
作者 wan-jun zhang Li-Qiang Wu +2 位作者 Jun Wang Sheng-Yun Lin Bo Wang 《World Journal of Clinical Cases》 SCIE 2022年第23期8242-8248,共7页
BACKGROUND Hepatitis-associated aplastic anemia(HAAA) is a rare condition. Patients with HAAA usually present with acute hepatitis, jaundice and significantly increased transaminase. After 1–2 mo, hepatitis gradually... BACKGROUND Hepatitis-associated aplastic anemia(HAAA) is a rare condition. Patients with HAAA usually present with acute hepatitis, jaundice and significantly increased transaminase. After 1–2 mo, hepatitis gradually improves, but progressive hemocytopenia, bone marrow hematopoietic failure, and severe or extremely severe aplastic anemia are manifest. Most cases of HAAA are fulminant and usually lethal if left untreated. The literature on Epstein–Barr virus(EBV)-associated HAAA is sparse.CASE SUMMARY We report a 30-year-old man who was admitted to our hospital because of pale yellow urine and skin with a simultaneous decrease in peripheral blood ternary cells. We made a diagnosis of EBV-associated HAAA. The treatment strategy for this patient included eltrombopag, an immunosuppressive regimen of rabbit antihuman thymocyte immunoglobulin, cyclosporine, and supportive care. The patient was discharged in normal physical condition after five months. A hemogram performed on follow-up revealed that he had achieved a complete response.CONCLUSION Eltrombopag plus anti-thymocyte globubin and cyclosporine may be a therapeutic option for EBV-associated HAAA.Larger studies are warranted to confirm. 展开更多
关键词 Epstein-Barr virus Hepatitis-associated aplastic anemia Immunosuppressive therapy ELTROMBOPAG Case report
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部